Biotech

Small Cap News Movers: Your Daily Digest of Stocks Making Moves on Market News

The past week has seen significant movements in the stock market, with several companies making notable gains and setting the…

Read More »

Shuttle Pharma Showcases Cancer Treatment Advancements at Planet MicroCap Vegas 2025

Shuttle Pharmaceuticals (NASDAQ: SHPH) took center stage at the Planet MicroCap Showcase: VEGAS 2025 on April 23, offering investors and…

Read More »

Regencell Bioscience (NASDAQ: RGC): 5 Min Deep Dive

In the volatile world of small-cap stocks, few names have grabbed investor attention like Regencell Bioscience (NASDAQ: RGC). Once a…

Read More »

Small Cap News Movers: Your Daily Digest of Stocks Making Moves on Market News

In today’s edition of Small Cap News Movers, we spotlight some of the most active and news-driven small-cap stocks. From…

Read More »

5-Minute Deep Dive Scorecard: Is Shuttle Pharmaceuticals (NASDAQ: SHPH) Ready for a Massive Breakout?

Biotech can be brutal, but when a tiny stock with a tight float and a powerful narrative starts to run,…

Read More »

Quantum BioPharma Taps Anti Naked Short Selling Advocate, Scores Nationwide Distribution Deal for Alcohol Detox Brand unbuzzd

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) is doubling down on two fronts—market advocacy and product expansion. This week,…

Read More »

Shuttle Pharma Targets Prostate Cancer With PSMA Ligand Breakthrough

Shuttle Pharmaceuticals (NASDAQ: SHPH) is advancing its mission to revolutionize prostate cancer treatment. On April 10, 2025, the company announced…

Read More »

Small Cap News Movers: Your Daily Digest of Stocks Making Moves on Market News

The broader market experienced mixed performance to start the week, with major indices continuing to display volatility. On Monday, Dow…

Read More »

Soleno Therapeutics: Navigating the Path to Profitability with Vykat XR

Summary First-Mover Advantage: Soleno has the market to itself until competition intensifies. High Sales Potential: Projected sales of $876 million…

Read More »

Quantum BioPharma Expands Reach With New unbuzzd Launch and Cutting-Edge MS Clinical Study

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) is making headlines in April, launching its innovative alcohol detox drink, unbuzzd™,…

Read More »
Back to top button